Gene: KDR
Official Full Name: kinase insert domain receptorprovided by HGNC
Gene Summary: Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA15110 | KDR Knockout cell line (AC16) | Human | KDR | 1:3-1:4 | negative | Online Inquiry |
| KOA30553 | KDR Knockout cell line (BEAS-2B) | Human | KDR | 1:3~1:4 | negative | Online Inquiry |
| KOA45979 | KDR Knockout cell line (U-2932) | Human | KDR | 1:2-1:4 | negative | Online Inquiry |
| KOA61365 | KDR Knockout cell line (TPC-1) | Human | KDR | 1:5-1:8 | negative | Online Inquiry |
| KOA76793 | KDR Knockout cell line (NCM460) | Human | KDR | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.